Drug intelligence / Profile preview

Lovaza + Curcumin C3 Complex

Development stage
Unknown
Lead developer
Moffitt Cancer Center
Modality
Small Molecules
Administration
Oral
01

Overview

Lovaza + Curcumin C3 Complex is an investigational combination therapy being evaluated for the reduction of pulmonary nodules in current and former smokers. Curcumin C3 Complex is a standardized extract of curcuminoids (curcumin, demethoxycurcumin, and bisdemethoxycurcumin) derived from turmeric root, known for its anti-inflammatory and antioxidant properties. Lovaza is a prescription-strength omega-3 acid ethyl ester concentrate. This combination is hypothesized to act synergistically to modulate intermediate endpoint biomarkers of lung cancer by targeting multiple biological pathways, including the Signal Transducer and Activator of Transcription 3 (STAT3) and Nuclear Factor-kappa B (NF-κB) pathways, as well as reducing inflammation-associated chemokines and cytokines. The H. Lee Moffitt Cancer Center and Research Institute is conducting Phase II clinical trials to assess the safety and efficacy of this regimen as a chemopreventive strategy for lung cancer prevention.

Brand names
LovazaCurcumin C3 Complex
Other names
omega-3-acid ethyl esters + curcuminoids
02

Targets

NF-κBSTAT3 (Signal Transducer and Activator of Transcription 3)IL10 (Interleukin-10)

Beyond the preview

Go deeper on Lovaza + Curcumin C3 Complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lovaza + Curcumin C3 Complex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call